Stocktoria
ONCOLYTICS BIOTECH INC ONCY
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2001-10-05
ONCOLYTICS BIOTECH INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| R&D expense | $13.3M | $15.4M |
| Operating income | -$28.7M | -$25.5M |
| Income tax | $79,000 | $95,000 |
| Net income | -$28.8M | -$22.8M |
| EPS (diluted) | $-0.30 | $-0.30 |
| Operating cash flow | -$20.1M | -$19.9M |
| Free cash flow | -$20.1M | -$20.1M |
| Cash & equivalents | $5.2M | $11.1M |
| Total assets | $7.6M | $13.4M |
| Total liabilities | $11.4M | $10.1M |
| Shareholders' equity | -$3.8M | $3.3M |
Source: SEC EDGAR filings · CIK 0001129928 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.